Clorox Company (The) (NYSE:CLX)‘s stock had its “equal weight” rating restated by investment analysts at Barclays PLC in a report released on Friday. They currently have a $136.00 price objective on the stock, down from their prior price objective of $140.00. Barclays PLC’s price target suggests a potential upside of 1.00% from the stock’s current price.

Several other equities research analysts have also issued reports on CLX. Zacks Investment Research lowered Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Thursday, April 6th. Citigroup Inc. raised their target price on Clorox Company (The) from $75.00 to $76.00 and gave the company a “neutral” rating in a research report on Friday, April 7th. Jefferies Group LLC started coverage on Clorox Company (The) in a research report on Tuesday, April 18th. They set a “hold” rating and a $138.00 target price for the company. Vetr lowered Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 target price for the company. in a research report on Tuesday, April 18th. Finally, Royal Bank Of Canada set a $115.00 target price on Clorox Company (The) and gave the company a “hold” rating in a research report on Monday, April 24th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $129.05.

Clorox Company (NYSE CLX) traded down 0.47% on Friday, reaching $134.02. 293,790 shares of the company’s stock traded hands. The firm has a market cap of $17.26 billion, a price-to-earnings ratio of 26.48 and a beta of 0.40. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The stock’s 50 day moving average is $134.34 and its 200 day moving average is $133.08.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period last year, the firm posted $1.30 EPS. The business’s revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts predict that Clorox Company will post $5.68 EPS for the current fiscal year.

WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/08/06/barclays-plc-lowers-clorox-company-the-nyseclx-price-target-to-136-00.html.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC increased its position in shares of Clorox Company (The) by 8.1% in the fourth quarter. FMR LLC now owns 97,861 shares of the company’s stock valued at $11,746,000 after buying an additional 7,357 shares in the last quarter. Macquarie Group Ltd. increased its position in shares of Clorox Company (The) by 6.5% in the fourth quarter. Macquarie Group Ltd. now owns 6,600 shares of the company’s stock valued at $792,000 after buying an additional 400 shares in the last quarter. Chevy Chase Trust Holdings Inc. increased its position in shares of Clorox Company (The) by 1.6% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 129,249 shares of the company’s stock valued at $17,427,000 after buying an additional 1,990 shares in the last quarter. Manning & Napier Advisors LLC increased its position in shares of Clorox Company (The) by 7.1% in the first quarter. Manning & Napier Advisors LLC now owns 22,261 shares of the company’s stock valued at $3,001,000 after buying an additional 1,478 shares in the last quarter. Finally, Fulton Bank N.A. bought a new position in shares of Clorox Company (The) during the first quarter valued at approximately $219,000. Institutional investors own 70.29% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.